Champions Oncology Inc (CSBR)
4.86
+0.01
(+0.21%)
USD |
NASDAQ |
May 01, 16:00
Champions Oncology Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| January 30, 2024 | 865.33 |
| January 29, 2024 | 875.56 |
| January 26, 2024 | 914.29 |
| January 25, 2024 | 891.64 |
| January 24, 2024 | 891.64 |
| January 23, 2024 | 894.56 |
| January 22, 2024 | 932.56 |
| January 19, 2024 | 974.79 |
| January 18, 2024 | 983.72 |
| January 17, 2024 | 1009.30 |
| January 16, 2024 | 991.03 |
| January 12, 2024 | 980.80 |
| January 11, 2024 | 907.72 |
| January 10, 2024 | 898.94 |
| January 09, 2024 | 912.10 |
| January 08, 2024 | 897.48 |
| January 05, 2024 | 885.79 |
| January 04, 2024 | 891.64 |
| January 03, 2024 | 898.94 |
| January 02, 2024 | 846.32 |
| December 29, 2023 | 821.46 |
| December 28, 2023 | 790.78 |
| December 27, 2023 | 773.97 |
| December 26, 2023 | 732.31 |
| December 22, 2023 | 732.31 |
| Date | Value |
|---|---|
| December 21, 2023 | 717.69 |
| December 20, 2023 | 726.46 |
| December 19, 2023 | 666.53 |
| December 18, 2023 | 676.77 |
| December 15, 2023 | 673.84 |
| December 14, 2023 | 698.69 |
| December 13, 2023 | 710.39 |
| December 12, 2023 | 673.84 |
| December 11, 2023 | 720.62 |
| December 08, 2023 | 726.46 |
| December 07, 2023 | 726.46 |
| December 06, 2023 | 741.08 |
| December 05, 2023 | 732.31 |
| December 04, 2023 | 767.39 |
| December 01, 2023 | 774.70 |
| November 30, 2023 | 752.77 |
| November 29, 2023 | 776.16 |
| November 28, 2023 | 789.32 |
| November 27, 2023 | 761.55 |
| November 24, 2023 | 803.93 |
| November 22, 2023 | 803.93 |
| November 21, 2023 | 783.47 |
| November 20, 2023 | 796.63 |
| November 17, 2023 | 799.55 |
| November 16, 2023 | 817.09 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
5.544
Minimum
Dec 20 2022
1009.30
Maximum
Jan 17 2024
63.06
Average
19.23
Median
Sep 16 2020
Price to Book Value Benchmarks
| AIM ImmunoTech Inc | 2.039 |
| Perspective Therapeutics Inc | 13.39 |
| Protalix BioTherapeutics Inc | 2.633 |
| Electromed Inc | 3.744 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 1.334 |
| PEG Ratio | -0.0319 |
| Price | 4.86 |
| Earnings Yield | -14.85% |
| Market Cap | 65.93M |
| PEGY Ratio | -0.0319 |